Search
for
Sort by
Research 30 of 72
- Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib
- Pustular Eruption in a Patient Treated With Trametinib
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies
- Hydrogel-Forming Microneedles for Transdermal Drug Delivery
- Biological therapy in the treatment of melanoma
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Drug-induced acne
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- An antimicrobial microneedle patch promotes functional healing of infected wounds through controlled release of adipose tissue-derived apoptotic vesicles
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Management of Toxicities of Targeted Therapies
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Graft-versus-host disease with acute hair loss: A distinctive manifestation of chronic graft-versus-host disease
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Hair Changes due to Drugs
- Poster Abstracts
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men